In ₹ Crore except Per Share Latest Annual	SURAKSHA FY26	KRSNAA FY26	HEALTHX FY26	NEPHROPLUS FY26	Peer Average
Valuation — at last close
P/E	51.71×	◆ 15.91×	754.59×	74.12×	281.54× -82%
P/B	6.80×	1.65×	◆ 1.39×	5.65×	2.89× +135%
EV/EBITDA	17.17×	8.44×	◆ -19.27×	26.26×	5.14× +234%
Market Cap	₹1,664 Cr	₹1,615 Cr	₹888 Cr	₹6,307 Cr	₹2,937 Cr -43%
Growth
Revenue CAGR 3Y	—	◆ 16.63%	8.26%	—	12.45%
Revenue CAGR 5Y	—	—	19.20%	—	19.20%
Net Income CAGR 3Y	—	17.76%	—	—	17.76%
Revenue YoY (latest Q)	20.75%	22.05%	◆ 49.73%	—	35.89% -42%
Net Income YoY (latest Q)	◆ 40.00%	-19.34%	-92.53%	—	-55.94% +172%
Profitability
EBITDA Margin	◆ 30.73%	27.42%	-3.95%	22.72%	15.40% +100%
Net Income Margin	10.12%	◆ 13.13%	-0.11%	7.69%	6.90% +47%
Return on Common Equity	◆ 14.11%	10.89%	0.18%	6.88%	5.98% +136%
Return on Capital Employed	◆ 15.88%	9.62%	—	11.63%	10.63% +49%
Return on Assets	◆ 8.04%	6.53%	-0.15%	5.22%	3.87% +108%
Credit & Quality
Total Debt/Equity	◆ 0.01×	0.55×	0.03×	0.07×	0.22× -95%
Interest Coverage	◆ 4.30×	3.53×	-75.12×	2.26×	-23.11× +119%
Scale — latest FY
Revenue / Total Income	₹310 Cr	₹773 Cr	₹1,319 Cr	₹999 Cr	₹1,030 Cr -70%
Net Income	₹31.4 Cr	₹101 Cr	−₹1.4 Cr	₹76.8 Cr	₹58.9 Cr -47%
Total Assets	₹448 Cr	₹1,824 Cr	₹936 Cr	₹1,471 Cr	₹1,410 Cr -68%
EPS	₹6.18	₹31.3	₹0.37	₹8.48	₹13.38 -54%
Book Value per Share	₹47.01	₹302.23	₹201.47	₹111.27	₹204.99 -77%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.